M. Piérart

14.7k citations

69 papers · 10.7k indexed · 9 hit papers · h-index 33

Impact in

Radiation top 0.1%
- Advanced Radiotherapy Techniques
Cancer Research top 0.2%
- Breast Cancer Treatment Studies

Papers in

Otorhinolaryngology 9
- Head and Neck Cancer Studies 9
Radiation 17
- Advanced Radiotherapy Techniques 17

Co-authors: Laurence Collette M. Bolla Harry Bartelink Philip Poortmans René‐Olivier Mirimanoff Jacques Bernier J.J. Jager Jean-Claude Horiot
Journals: European Journal of Cancer (13 papers)Radiotherapy and Oncology (12 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Journal of Clinical Oncology (5 papers)New England Journal of Medicine (3 papers)
Partner nations: France Belgium Netherlands

In The Last Decade

M. Piérart

68 papers receiving 10.4k citations

Hit Papers

9 papers align trajectories log scale

Duration of Androgen Suppression in the Treatment of Prostate Cancer 2009 · 658 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 New England Journal of Medicine
2007 Journal of Clinical Oncology
2005 The Lancet
2005 The Lancet
2002 The Lancet
2001 New England Journal of Medicine
1997 New England Journal of Medicine
1997 Journal of Clinical Oncology
1996 International Journal of Radiation Oncology*Biology*Physics

Peers

Countries citing papers authored by M. Piérart

Since Specialization

Citations

This map shows the geographic impact of M. Piérart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Piérart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Piérart more than expected).

Fields of papers citing papers by M. Piérart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Piérart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Piérart. The network helps show where M. Piérart may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Piérart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Piérart Line = papers co-authored together M. Piérart links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) Acta Oncologica ·Oscar Matzinger, Balan Aa, Philip Poortmans, Laurence Collette, H. Struikmans, Walter Van den Bogaert, Alain Fourquet, Harry Bartelink, L. Laqueur, Ákos Gulybán, M. Piérart, Geertjan van Tienhoven, (unknown), (unknown)	2010	91
2	Duration of Androgen Suppression in the Treatment of Prostate Cancer New England Journal of Medicine ·M. Bolla, 陈琳陈琳, Geertjan van Tienhoven, Alphonsus C. M. van den Bergh, Jorg R. Oddens, Philip Poortmans, Eliahu Gez, P. Kil, A. Akdaş, Guy Soete, 正毅小川, Gustavo Henrique da Silva Lopes, E. Musat, M. Piérart, Murielle Mauer, Laurence Collette Hit paper breakdown →	2009	658
3	Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder Acta Oncologica ·Philip Poortmans, Pierre Richaud, Laurence Collette, S Bruderliaĭn, M. Piérart, Francisco José Armenteros Ruiz, M. Bolla, (unknown)	2008	6
4	Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes European Journal of Cancer ·E. Musat, Philip Poortmans, Walter Van den Bogaert, H. Struikmans, Alain Fourquet, Harry Bartelink, Carine Kirkove, Volker Budach, M. Piérart, Laurence Collette	2007	24
5	Postoperative Radiotherapy After Radical Prostatectomy: A Randomised Controlled Trial (EORTC Trial 22911) The Journal of Urology ·M. Bolla, Hendrik Van Poppel, Laurence Collette, Άννα Αγγελούση, K. Vekemans, L. Da Pozzo, T.M. De Reijke, A. Verbaeys, J.-F. Bosset, R. Van Velthoven, J Maréchal, Pierre Scalliet, Karin Haustermans, M. Piérart	2006	32
6	Patients at high risk of progression after radical prostatectomy: Do they all benefit from immediate post-operative irradiation? (EORTC trial 22911) European Journal of Cancer ·Laurence Collette, Hendrik Van Poppel, M. Bolla, Paul Van Cangh, K. Vekemans, L. Da Pozzo, Theo M. de Reijke, A. Verbaeys, Jean-François Bosset, M. Piérart	2005	53
7	Quality assurance in the EORTC phase III randomised ‘boost vs. no boost’ trial for breast conserving therapy: Comparison of the results of two individual case reviews performed early and late during the accrual period Radiotherapy and Oncology ·Philip Poortmans, L. Laqueur, J.B. Davis, Harry Bartelink, Jean-Claude Horiot, M. Piérart, Laurence Collette, Geertjan van Tienhoven	2005	22
8	Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial The Lancet ·Martin J. van den Bent, D Afra, Olivier De Witte, Mohamed Ben Hassel, S Schraub, Khê Hoang‐Xuan, P. Malmström, Laurence Collette, M. Piérart, René‐Olivier Mirimanoff, Nitil Jakhar Hit paper breakdown →	2005	679
9	Is immediate post-operative radiation of pT3NO prostate cancer a safe treatment? Results of EORTC-trial 22911. The Journal of Urology ·H. Van Poppel, M Bolla, Paul Van Cangh, K. Vekemans, P. Rigatti, H. Bock, A. Verbaeys, R. Van Velthoven, Samara Alasadi, Karin Haustermans, Pierre Scalliet, Laurence Collette, M. Piérart	2003	2
10	The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC) European Journal of Cancer ·蔡卓郑海林, Philip Poortmans, Jacques Bernier, J.C. Horiot, Kjell Arne Johansson, Richa Khera, 楊勝舜, G. Garavaglia, M. Piérart, Emmanuel van der Schueren	2003	37
11	Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·H. Bartelink, P Poortmans, Rebecca Carey Lyles, Jacques Borger, Justyna Rajchert, W.J. Hoogenraad, W. Van den Bogaert, I. Barillot, Alain Fourquet, Laurence Collette, M. Piérart, J.C. Horiot	2002	1
12	Acute Toxicity of Conventional Radiation Therapy for High-Risk Prostate Cancer in EORTC Trial 22863 European Urology ·Alfredo Zurlo, Laurence Collette, Geertjan van Tienhoven, Jennifer Alejandra Cardenas Castañeda, Padraig Warde, Jonathan Dubois, Jon Daniel Tashman, Guy Storme, J. Bernier, Abraham Kuten, M. Piérart, M. Bolla	2002	12
13	The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial Radiotherapy and Oncology ·Conny Vrieling, Laurence Collette, Alain Fourquet, W.J. Hoogenraad, J.C. Horiot, J.J. Jager, M. Piérart, Philip Poortmans, H. Struikmans, B. Maat, Erik Van Limbergen, Harry Bartelink	2000	250
14	ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC Radiotherapy and Oncology ·Jacques Bernier, J. Denekamp, Anamaria Rojas, M. Trovò, J.C. Horiot, Han Hamers, Paolo Antognoni, Olav Dahl, Pierre Richaud, J.H.A.M. Kaanders, M. van Glabbeke, M. Piérart	1999	40
15	Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844) European Journal of Cancer ·G.M. Kiebert, Desmond Curran, N.K. Aaronson, M. Bolla, Johan Menten, E.H.J.M. Rutten, E Nordman, M E Silvestre, M. Piérart, A.B.M.F. Karim	1998	202
16	Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial Radiotherapy and Oncology ·Jean-Claude Horiot, P. Bontemps, Walter Van den Bogaert, R. Le Fur, Лолита Мищенко, M. Bolla, Jacques Bernier, Antoine Lusinchi, Martin Stuschke, J. López-Torrecilla, Adrian C. Begg, M. Piérart, Laurence Collette	1997	389
17	Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin New England Journal of Medicine ·M. Bolla, Dionisio González, Padraig Warde, J.B. Dubois, René‐Olivier Mirimanoff, Guy Storme, Jacques Bernier, Abraham Kuten, Cora N. Sternberg, Thierry Gil, Laurence Collette, M. Piérart Hit paper breakdown →	1997	1190
18	Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. Journal of Clinical Oncology ·Harry Bartelink, F. Roelofsen, F. Eschwège, P Rougier, Jean-François Bosset, D. González González, D. Peiffert, M. van Glabbeke, M. Piérart Hit paper breakdown →	1997	898
19	Patient population analysis in eortc trial 22881/10882 on the role of a booster dose in breast-conserving therapy European Journal of Cancer ·Daniela Juarez, W. Van den Bogaert, M. van Glabbeke, M. Piérart, Harry Bartelink, Jean-Claude Horiot, Alain Fourquet, H. Struikmans, Han Hamers, R.-P. Müller, W.J. Hoogenraad, J.J. Jager, Emmanuel van der Schueren	1994	22
20	Immunopharmacological properties of RES-1080 in vitro Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Thierry Appelboom, Nicole Mairesse, M. Piérart, Marguerite Koutsoukos, Jacques Bentin	1990	0

About M. Piérart

M. Piérart is a scholar working on Otorhinolaryngology, Radiation, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 69 papers that have together received 10.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (18 papers), Advanced Radiotherapy Techniques (17 papers), Breast Lesions and Carcinomas (13 papers), Head and Neck Cancer Studies (9 papers), Brain Metastases and Treatment (7 papers) and Colorectal Cancer Surgical Treatments (7 papers). The work is most often cited by research in Radiation (2.2k citations), Cancer Research (3.0k citations), Pulmonary and Respiratory Medicine (6.1k citations), Genetics (1.6k citations) and Otorhinolaryngology (430 citations). M. Piérart has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Laurence Collette, M. Bolla, Harry Bartelink, Philip Poortmans, René‐Olivier Mirimanoff, Jacques Bernier, J.J. Jager, Jean-Claude Horiot, Alain Fourquet and H. Struikmans. Their work appears in journals such as European Journal of Cancer, Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact